Nektar Therapeutics | NKTR - Mitarbeiter Gesamtzahl





Mitarbeiter Veränderung Datum
Agios Pharmaceuticals 486 103 2024-12
ALKERMES 1.8K 300 2024-12
Alterity Therapeutics Limited AUD 12 1 2022-06
Amgen 28K 1.3K 2024-12
Baxter International 38K 22K 2024-12
BioCryst Pharmaceuticals 536 5 2023-12
Biogen 7.6K 35 2024-12
Bristol-Myers Squibb 34.1K 0 2024-12
Cara Therapeutics 55 51 2023-12
Cipla 30.31K 2.55K 2025-12
Dr.Reddys Laboratories 26.94K 601 2025-12
Eisai 13.51K 2.44K 2025-12
Eli Lilly 47K 4K 2024-12
Esperion Therapeutics 240 41 2023-12
Exelixis 1.15K 163 2025-12
Gilead Sciences 17.6K 400 2024-12
GlaxoSmithKline 69.4K 20.7K 2022-12
Grifols EUR 23.83K 89 2024-12
Halozyme Therapeutics 350 23 2024-12
Incyte 2.62K 93 2024-12
Ionis Pharmaceuticals 1.07K 142 2024-12
Ironwood Pharmaceuticals 267 48 2023-12
Karyopharm Therapeutics 325 60 2023-12
MacroGenics 339 18 2023-12
Merck 75K 3K 2024-12
Nektar Therapeutics 137 79 2023-12
Neurocrine Biosciences 1.8K 400 2024-12
Novartis USD 101.7K 2.62K 2022-12
Pfizer 81K 7K 2024-12
Roche Holding 103.61K 2.69K 2022-12
Sarepta Therapeutics 1.37K 58 2024-12
Takeda 47.46K 1.83K 2025-12
Xencor 250 30 2024-12